These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25513957)

  • 21. Studying the effect of lipid chain length on the precipitation of a poorly water soluble drug from self-emulsifying drug delivery system on dispersion into aqueous medium.
    Prasad D; Chauhan H; Atef E
    J Pharm Pharmacol; 2013 Aug; 65(8):1134-44. PubMed ID: 23837581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prodrug strategy for the oral delivery of a poorly soluble HCV NS5B thumb pocket 1 polymerase inhibitor using self-emulsifying drug delivery systems (SEDDS).
    Beaulieu PL; De Marte J; Garneau M; Luo L; Stammers T; Telang C; Wernic D; Kukolj G; Duan J
    Bioorg Med Chem Lett; 2015 Jan; 25(2):210-5. PubMed ID: 25515558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
    Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
    Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simplified method to screen for in-vivo performance of oral lipid formulations.
    Kilic M; Dressman J
    J Pharm Pharmacol; 2014 May; 66(5):615-23. PubMed ID: 24313318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease.
    Borkar N; Mu H; Holm R
    Asian J Pharm Sci; 2018 Nov; 13(6):507-517. PubMed ID: 32104425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery.
    Tashtoush BM; Bennamani AN; Al-Taani BM
    Pharm Dev Technol; 2013; 18(4):834-43. PubMed ID: 23030413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems.
    Heshmati N; Cheng X; Dapat E; Sassene P; Eisenbrand G; Fricker G; Müllertz A
    J Pharm Pharmacol; 2014 Nov; 66(11):1567-75. PubMed ID: 24961657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymatic characterization of lipid-based drug delivery systems.
    Ljusberg-Wahren H; Seier Nielsen F; Brogård M; Troedsson E; Müllertz A
    Int J Pharm; 2005 Jul; 298(2):328-32. PubMed ID: 15979260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
    Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
    Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved corneal pilocarpine permeability with O,O'-(1,4-xylylene) bispilocarpic acid ester double prodrugs.
    Suhonen P; Järvinen T; Rytkönen P; Peura P; Urtti A
    Pharm Res; 1991 Dec; 8(12):1539-42. PubMed ID: 1808621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, physicochemical properties and antiviral activities of ester prodrugs of ganciclovir.
    Patel K; Trivedi S; Luo S; Zhu X; Pal D; Kern ER; Mitra AK
    Int J Pharm; 2005 Nov; 305(1-2):75-89. PubMed ID: 16242278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis.
    Simões MF; Valente E; Gómez MJ; Anes E; Constantino L
    Eur J Pharm Sci; 2009 Jun; 37(3-4):257-63. PubMed ID: 19491013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems.
    Anby MU; Williams HD; McIntosh M; Benameur H; Edwards GA; Pouton CW; Porter CJ
    Mol Pharm; 2012 Jul; 9(7):2063-79. PubMed ID: 22656917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of esterase in the hydrolysis of 3',5'-diesters of 5-fluoro-2'-deoxyuridine in relation to the structure of the diester prodrugs.
    Kawaguchi T; Suzuki Y; Nakahara Y; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1985 Jan; 33(1):301-7. PubMed ID: 3159490
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
    Porter CJ; Trevaskis NL; Charman WN
    Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of quercetin-3-O-acyl esters as topical prodrugs.
    Montenegro L; Carbone C; Maniscalco C; Lambusta D; Nicolosi G; Ventura CA; Puglisi G
    Int J Pharm; 2007 May; 336(2):257-62. PubMed ID: 17257788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Design, optimization and quality evaluation of curcumin self-emulsifying drug delivery system (SEDDS)].
    Wang YH; Wang SH; Yang RP; Ma XJ
    Zhong Yao Cai; 2010 Dec; 33(12):1933-7. PubMed ID: 21548374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism evaluation of biomimetic prodrugs by in vitro models and mass spectrometry.
    Lalanne M; Khoury H; Deroussent A; Bosquet N; Benech H; Clayette P; Couvreur P; Vassal G; Paci A; Andrieux K
    Int J Pharm; 2009 Sep; 379(2):235-43. PubMed ID: 19467308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
    Hsu SH; Wen CJ; Al-Suwayeh SA; Chang HW; Yen TC; Fang JY
    Nanotechnology; 2010 Oct; 21(40):405101. PubMed ID: 20823498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.